BELL Belluscura Plc

8 July 2024

Belluscura plc

("Belluscura", the "Company"}

Result of General Meeting

Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that at the General Meeting held earlier today both the resolutions put to the meeting were duly approved by Shareholders:

The Company is pleased to confirm that, as announced on 2 July 2024, following Shareholder approval for the Resolutions as they relate to the issue of the Loan Note Placing, together with the recent Share Subscriptions for new ordinary shares, the Company has raised total gross proceeds of approximately £1.92 million.

In accordance with the terms of the Loan Note Placing Agreement, following passing of the Resolutions, the Placing Loan Notes will be issued on 9 July 2024.

The net proceeds of the Loan Note Placing and Share Subscriptions will be used for working capital purposes to support the growth in both the X-PLOR® and DISCOV-R^TM portable oxygen concentrator devices sales, as set out in the Announcement and the Letter to Shareholders dated 2 July 2024.

Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to such terms in the Announcement made by the Company at 14:30 on 2 July 2024 and the letter to Shareholders dated 2 July 2024, which constituted a supplement to the Circular dated 14 June 2024.

For further information please contact: